Health
Bedside trial of COVID-19 ICU patients sees hydrocortisone improve recovery – Mirage News
Researchers have found that intravenous hydrocortisone improves recovery and survival for critically ill COVID-19 patients. The finding comes as a result…
- Researchers have found that intravenous hydrocortisone improves recovery and survival for critically ill COVID-19 patients.
- The finding comes as a result of the REMAP-CAP trial that was set up by a group of intensive care specialists from around the world to future-proof for pandemics like COVID-19.
- COVID-19 patients from more than 200 intensive care units around the world have been part of this adaptive randomised trial.
A global study, led from Mo…
Click here to view the original article.
Continue Reading
-
Noosa News16 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News21 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up
-
Noosa News14 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News23 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common